These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8607601)

  • 1. Phenelzine-induced fulminant hepatic failure.
    Gómez-Gil E; Salmerón JM; Mas A
    Ann Intern Med; 1996 Apr; 124(7):692-3. PubMed ID: 8607601
    [No Abstract]   [Full Text] [Related]  

  • 2. The hepatic injury of monoamine oxidase inhibitors.
    Zimmerman HJ; Ishak KG
    J Clin Psychopharmacol; 1987 Aug; 7(4):211-3. PubMed ID: 3624504
    [No Abstract]   [Full Text] [Related]  

  • 3. Seizures in a diabetic patient on monoamine oxidase inhibitors.
    Albareda M; Udina C; Escartín A; Corcoy R
    Am J Emerg Med; 1999 Jan; 17(1):107-8. PubMed ID: 9928719
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenelzine Withdrawal-Associated Psychosis and Mania.
    Shao W; Brown T; Ayub S
    J Clin Psychopharmacol; 2017 Aug; 37(4):480-482. PubMed ID: 28609305
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract]   [Full Text] [Related]  

  • 6. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I; Spigset O
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):746-8. PubMed ID: 19373300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of chronic phenelzine treatment on REM sleep: report of three patients.
    Landolt HP; de Boer LP
    Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S63-7. PubMed ID: 11682276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline.
    Fenwick MJ; Muwanga CL
    J Accid Emerg Med; 2000 Mar; 17(2):143-4. PubMed ID: 10718244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized drug interaction programs: how reliable?
    Kraft KE; Dore FH
    JAMA; 1996 Apr; 275(14):1087. PubMed ID: 8601924
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphadenopathy associated with monoamine oxidase inhibitors.
    Kallab AM; Marley EM; Frei-Lahr D
    Am J Hematol; 1999 Feb; 60(2):167. PubMed ID: 9929114
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors revisited: what you should know.
    Goldberg JF; Thase ME
    J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke resulting from a rapid switch from phenelzine to tranylcypromine.
    Mattes JA
    J Clin Psychiatry; 1998 Jul; 59(7):382. PubMed ID: 9714269
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipyrine elimination by patients under treatment with monoamine oxidase inhibitors.
    Smith SE; Lambourn J; Tyrer PJ
    Br J Clin Pharmacol; 1980 Jan; 9(1):21-5. PubMed ID: 7356888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenelzine-induced sexual dysfunction treated with sildenafil.
    Gupta S; Masand P; Ashton AK; Berry SL
    J Sex Marital Ther; 1999; 25(2):131-5. PubMed ID: 10327382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors.
    Durmuş B; Osse RJ; Emmer B; van Kooten F
    Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 27922229
    [No Abstract]   [Full Text] [Related]  

  • 19. [On hepatocellular damage caused by MAOI drugs].
    Barberini E; Malagoli G
    Minerva Med; 1971 Mar; 62(23):1220-4. PubMed ID: 5552928
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine oxidase inhibitors.
    Blackwell B
    Br J Psychiatry; 1986 Feb; 148():216-7. PubMed ID: 3697591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.